BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20488164)

  • 41. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.
    Hopfner M; Sutter AP; Huether A; Baradari V; Scherubl H
    World J Gastroenterol; 2006 Sep; 12(35):5635-43. PubMed ID: 17007015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
    Hamilton N; Austin D; Márquez-Garbán D; Sanchez R; Chau B; Foos K; Wu Y; Vadgama J; Pietras R
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.
    Mancini M; Gariboldi MB; Taiana E; Bonzi MC; Craparotta I; Pagin M; Monti E
    Br J Cancer; 2014 Jun; 110(12):2865-73. PubMed ID: 24853185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells.
    Esparís-Ogando A; Ocaña A; Rodríguez-Barrueco R; Ferreira L; Borges J; Pandiella A
    Ann Oncol; 2008 Nov; 19(11):1860-9. PubMed ID: 18641009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Insulin-like growth factor-1 induced activation and expression of signal transducers and activators of transcription-3 in scleral fibroblast of guinea pigs].
    Zhu ZC; Zhang JS; Ji XY; Wang YF; Chen Y; Li XJ
    Zhonghua Yan Ke Za Zhi; 2007 Dec; 43(12):1125-9. PubMed ID: 18331685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line.
    Ekyalongo RC; Mukohara T; Kataoka Y; Funakoshi Y; Tomioka H; Kiyota N; Fujiwara Y; Minami H
    Invest New Drugs; 2013 Apr; 31(2):293-303. PubMed ID: 22828916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Luteolin inhibits angiogenesis of the M2‑like TAMs via the downregulation of hypoxia inducible factor‑1α and the STAT3 signalling pathway under hypoxia.
    Fang B; Chen X; Wu M; Kong H; Chu G; Zhou Z; Zhang C; Chen B
    Mol Med Rep; 2018 Sep; 18(3):2914-2922. PubMed ID: 30015852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
    Huang GS; Brouwer-Visser J; Ramirez MJ; Kim CH; Hebert TM; Lin J; Arias-Pulido H; Qualls CR; Prossnitz ER; Goldberg GL; Smith HO; Horwitz SB
    Clin Cancer Res; 2010 Jun; 16(11):2999-3010. PubMed ID: 20404007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells.
    Ioannou N; Seddon AM; Dalgleish A; Mackintosh D; Modjtahedi H
    BMC Cancer; 2013 Jan; 13():41. PubMed ID: 23367880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.
    Bielen A; Box G; Perryman L; Bjerke L; Popov S; Jamin Y; Jury A; Valenti M; Brandon Ade H; Martins V; Romanet V; Jeay S; Raynaud FI; Hofmann F; Robinson SP; Eccles SA; Jones C
    Proc Natl Acad Sci U S A; 2012 May; 109(20):E1267-76. PubMed ID: 22529373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.
    Bruchim I; Sarfstein R; Reiss A; Flescher E; Werner H
    Cancer Lett; 2014 Oct; 352(2):214-9. PubMed ID: 24997432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.
    Garofalo C; Mancarella C; Grilli A; Manara MC; Astolfi A; Marino MT; Conte A; Sigismund S; Carè A; Belfiore A; Picci P; Scotlandi K
    Mol Endocrinol; 2012 Sep; 26(9):1603-16. PubMed ID: 22798295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma.
    Kang SH; Yu MO; Park KJ; Chi SG; Park DH; Chung YG
    Neurosurgery; 2010 Nov; 67(5):1386-95; discussion 1395. PubMed ID: 20871442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines.
    Urbanska K; Trojanek J; Del Valle L; Eldeen MB; Hofmann F; Garcia-Echeverria C; Khalili K; Reiss K
    Oncogene; 2007 Apr; 26(16):2308-17. PubMed ID: 17016438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
    Li T; Wang J; Liu P; Chi J; Yan H; Lei L; Li Z; Yang B; Wang X
    Oncotarget; 2017 Jul; 8(29):47269-47283. PubMed ID: 28521298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy.
    Zhou H; Rao J; Lin J; Yin B; Sheng H; Lin F; Zhang N; Yang L
    Oncol Rep; 2011 Jun; 25(6):1565-71. PubMed ID: 21455580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells.
    Nilsson CL; Dillon R; Devakumar A; Shi SD; Greig M; Rogers JC; Krastins B; Rosenblatt M; Kilmer G; Major M; Kaboord BJ; Sarracino D; Rezai T; Prakash A; Lopez M; Ji Y; Priebe W; Lang FF; Colman H; Conrad CA
    J Proteome Res; 2010 Jan; 9(1):430-43. PubMed ID: 19899826
    [TBL] [Abstract][Full Text] [Related]  

  • 58. STAT3 or USF2 contributes to HIF target gene specificity.
    Pawlus MR; Wang L; Murakami A; Dai G; Hu CJ
    PLoS One; 2013; 8(8):e72358. PubMed ID: 23991099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets.
    Gest C; Mirshahi P; Li H; Pritchard LL; Joimel U; Blot E; Chidiac J; Poletto B; Vannier JP; Varin R; Mirshahi M; Cazin L; Pujade-Lauraine E; Soria J; Soria C
    Cancer Lett; 2012 Apr; 317(2):207-17. PubMed ID: 22120672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-like growth factor 1 receptor signaling regulates embryonic epicardial cell proliferation through focal adhesion kinase pathway.
    Yan Y; Qin Q; Wu L; Jing X; Deng S; She Q
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):976-983. PubMed ID: 30184089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.